PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Clomifene→

Clomifene PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
911-45-5
Molecular formula
C26H28ClNO
Molecular weight
406 g/mol
Drug class
Selective oestrogen-receptor modulator (SERM)non-steroidal ovulation stimulant
Mechanism of action
Interacts with oestrogen receptors in the hypothalamus and alters oestrogen feedback, increasing pituitary gonadotrophin output and promoting ovarian follicular maturation and ovulation.
Indications / reported uses
  • Induction of ovulation in appropriately selected anovulatory or oligo-ovulatory women seeking pregnancy; use requires assessment of the cause of infertility and product-specific eligibility

Sources: UK SmPC — Clomifene 50 mg tablets · US DailyMed — Clomid prescribing information · NCI Drug Dictionary

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Clomifene PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Clomifene Permitted Daily Exposure (PDE) report (the Clomifene PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Clomifene Occupational Exposure Limit (OEL) report (the Clomifene OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.